The NEW 5977B High Efficiency Source (HES) GC/MSD builds on a tradition of providing the most trusted single-quadrupole GC/MS system. The ultra-efficient EI source maximizes the number of ions that ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Agilent J&W HP-5ms has very low bleed characteristics that are ideal for GC/MS. The column has excellent inertness for active compounds, including acidic and basic compounds, and improved ...
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback